MedTrace Logo

Anesthesia in Patients With Mitochondrial Disease

NCT02053766 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2024-08-28

Study results available
· View outcomes & findings →

Summary

This pilot study is a prospective, randomized clinical trial to evaluate the effect of anesthesia in the mitochondrial dysfunction patient.

Conditions

  • Mitochondrial Diseases

Interventions

DRUG

Sevoflurane

Sevoflurane up to 8% will be administered to study subjects

DRUG

Dexmedetomidine

Dexmedetomidine (Precedex) infusion starting at 1mcg/ kg/ hr will be administered to study subjects.

DRUG

Propofol

Propofol up to 50 mcg/ kg/min will be administered to study subjects.

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Maria Matuszczak, MD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-10
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02053766 on ClinicalTrials.gov